Trial of chemotherapy utilising carboplatin, vincristine, cyclophosphamide and etoposide for the treatment of central nervous system primitive neurectodermal tumours of childhood

Not Applicable

Completed

• Conditions: Brain and nervous system cancer; Cancer; Brain and nervous system

• Registration Number: ISRCTN37367725
• Lead Sponsor: Cancer Research UK (CRUK) (UK)

Brief Summary

1. 2003 results in https://www.ncbi.nlm.nih.gov/pubmed/12697884 (added 23/01/2019) 2. 2004 radiotherapy duration results in https://www.ncbi.nlm.nih.gov/pubmed/15001263 (added 23/01/2019) 3. 2004 patient stratification results in https://www.ncbi.nlm.nih.gov/pubmed/15328187 4. 2007 follow-up results in https://www.ncbi.nlm.nih.gov/pubmed/17878477 5. 2009 results for supratentorial primitive neuro-ectodermal tumours (SPNET) subset in https://www.ncbi.nlm.nih.gov/pubmed/19328574

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2000-01-28
• Study Start: 2001-07-01
• Last Update Posted: 11 February 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 0

Inclusion Criteria

1. Aged 3 to 16 years
2. Survival period of at least 1 week following surgery
3. Post-operative Computed Tomography (CT) scan and myelogram
4. No concomitant haematological disorder
5. No previous history of malignant disease

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ot provided at time of registration

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration